CD Fegan

779 total citations
20 papers, 599 citations indexed

About

CD Fegan is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, CD Fegan has authored 20 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in CD Fegan's work include Hematopoietic Stem Cell Transplantation (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). CD Fegan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). CD Fegan collaborates with scholars based in United Kingdom, United States and Belgium. CD Fegan's co-authors include Suparno Chakrabarti, K.E. Collingham, DW Milligan, Deenan Pillay, Denise White, Hazel M. Robinson, Peter Thompson, C Poynton, J. A. Whittaker and Husam Osman and has published in prestigious journals such as Annals of Oncology, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

CD Fegan

19 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CD Fegan United Kingdom 13 218 202 168 154 130 20 599
Marta Zelazko Argentina 15 198 0.9× 98 0.5× 106 0.6× 75 0.5× 60 0.5× 32 691
Chen‐Chung Chu Taiwan 18 140 0.6× 126 0.6× 193 1.1× 78 0.5× 22 0.2× 30 685
Mehdi Yeganeh Iran 15 116 0.5× 84 0.4× 187 1.1× 83 0.5× 56 0.4× 30 619
Ken Ishiyama Japan 17 141 0.6× 555 2.7× 42 0.3× 186 1.2× 136 1.0× 100 865
R Rokicka-Milewska Poland 12 111 0.5× 188 0.9× 50 0.3× 56 0.4× 59 0.5× 55 490
Marcos J. de Lima United States 16 111 0.5× 586 2.9× 64 0.4× 329 2.1× 74 0.6× 41 910
Monica Arenas United Kingdom 11 138 0.6× 116 0.6× 141 0.8× 62 0.4× 59 0.5× 19 874
Makito Tanaka Japan 15 89 0.4× 244 1.2× 67 0.4× 166 1.1× 75 0.6× 44 588
Étienne Daguindau France 17 215 1.0× 222 1.1× 34 0.2× 197 1.3× 58 0.4× 54 815
Woo Sung Min South Korea 16 125 0.6× 389 1.9× 27 0.2× 241 1.6× 79 0.6× 47 696

Countries citing papers authored by CD Fegan

Since Specialization
Citations

This map shows the geographic impact of CD Fegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CD Fegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CD Fegan more than expected).

Fields of papers citing papers by CD Fegan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CD Fegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CD Fegan. The network helps show where CD Fegan may publish in the future.

Co-authorship network of co-authors of CD Fegan

This figure shows the co-authorship network connecting the top 25 collaborators of CD Fegan. A scholar is included among the top collaborators of CD Fegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CD Fegan. CD Fegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Sheela, David Watkins, David Cunningham, et al.. (2004). Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma. Annals of Oncology. 15(9). 1413–1418. 37 indexed citations
2.
Bertoni, Francesco, et al.. (2002). Candidate Genes for the 11Q Abnormality in Chronic Lymphocytic Leukaemia (CLL). Clinical Science. 103(s47). 49P–49P.
3.
Chakrabarti, Suparno, K.E. Collingham, Husam Osman, CD Fegan, & DW Milligan. (2001). Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections. Bone Marrow Transplantation. 28(9). 879–881. 18 indexed citations
4.
Chakrabarti, Suparno, et al.. (2001). Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Bone Marrow Transplantation. 28(8). 759–763. 46 indexed citations
5.
Lester, Will, et al.. (2000). Respiratory failure during induction chemotherapy for acute myelomonocytic leukaemia (FAB M4Eo) with Ara‐C and all‐trans retinoic acid. British Journal of Haematology. 109(4). 847–850. 8 indexed citations
6.
Chakrabarti, Suparno, et al.. (2000). Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study. Bone Marrow Transplantation. 25(3). 277–282. 27 indexed citations
7.
Chakrabarti, Suparno, K.E. Collingham, CD Fegan, Deenan Pillay, & DW Milligan. (2000). Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?. Bone Marrow Transplantation. 26(3). 305–307. 72 indexed citations
8.
Oates, J, et al.. (2000). Philadelphia-positive T-ALL in a patient with follicular lymphoma. Bone Marrow Transplantation. 26(10). 1113–1115. 3 indexed citations
9.
Brown, Simon, S. Davies, CD Fegan, et al.. (1999). Haemostatic and fibrinolytic responses to bone marrow transplantation. British Journal of Haematology. 104(3). 468–474. 14 indexed citations
10.
Chakrabarti, Suparno, K.E. Collingham, CD Fegan, & DW Milligan. (1999). Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplantation. 23(11). 1209–1211. 70 indexed citations
11.
Fegan, CD, et al.. (1998). Circulating CD34+ counts and apheresis planning. Hematological Oncology. 16(2). 69–75. 6 indexed citations
12.
Fegan, CD, et al.. (1995). C‐myc amplification, double minutes and homogenous staining regions in a case of AML. British Journal of Haematology. 90(2). 486–488. 24 indexed citations
13.
Fegan, CD, et al.. (1995). All trans retinoic acid enhances human LAK activity. European Journal Of Haematology. 54(2). 95–100. 3 indexed citations
14.
Fegan, CD, Simon K. Jackson, & J. A. Whittaker. (1995). Antigenaemia during acute graft versus host disease.. Journal of Clinical Pathology. 48(2). 105–109. 3 indexed citations
15.
Fegan, CD, et al.. (1995). Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease.. PubMed. 9(12). 2003–8. 94 indexed citations
16.
Davies, S., et al.. (1995). Serum erythropoietin during autologous bone marrow transplantation: relationship to measures of erythroid activity.. PubMed. 17(2). 139–44. 12 indexed citations
17.
Fegan, CD, Huw B. Thomas, R Bailey-Wood, et al.. (1995). In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation.. PubMed. 16(2). 277–81. 11 indexed citations
18.
Jackson, Simon K., Joan Parton, Rosemary A. Barnes, C Poynton, & CD Fegan. (1993). Effect of IgM‐enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti‐endotoxin antibodies in bone marrow transplantation. European Journal of Clinical Investigation. 23(9). 540–545. 48 indexed citations
19.
Davies, S., I. Cavill, Neil Bentley, et al.. (1992). Evaluation of erythropoiesis after bone marrow transplantation: quantitative reticulocyte counting. British Journal of Haematology. 81(1). 12–17. 39 indexed citations
20.
Fegan, CD, et al.. (1990). The gut mucosal barrier in bone marrow transplantation.. PubMed. 5(6). 373–7. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Zelazko Breakdown of academic impact, for papers by Chen‐Chung Chu Breakdown of academic impact, for papers by Mehdi Yeganeh Breakdown of academic impact, for papers by Ken Ishiyama Breakdown of academic impact, for papers by R Rokicka-Milewska Breakdown of academic impact, for papers by Marcos J. de Lima Breakdown of academic impact, for papers by Monica Arenas Breakdown of academic impact, for papers by Makito Tanaka Breakdown of academic impact, for papers by Étienne Daguindau Breakdown of academic impact, for papers by Woo Sung Min
Rankless by CCL
2026